Innate Pharma cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 15 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Net Income | -22.98M | -11.38M | -76.29M | -28.56M | -60.41M | -0.08M | -59.28M | 0.62M | -8.14M | -26.67M | -52.86M | -24.16M | -57.24M | -22.81M | |
| Non-cash Items | -5.89M | -0.47M | -3.05M | -22.31M | -55.57M | -6.79M | -0.50M | -25.37M | -49.22M | -49.03M | |||||
| Change in Working Capital | -63.44M | -58.67M | -52.11M | -11.31M | -39.17M | -12.76M | -20.18M | -34.53M | 28.64M | -57.40M | -50.60M | ||||
| Change in Account Payables | -17.11M | -17.51M | |||||||||||||
| Cash from Operations | -63.91M | -61.72M | -37.53M | -66.87M | -19.54M | -12.48M | -35.03M | -7.37M | -61.41M | ||||||
| Investing Activities | |||||||||||||||
| Capital Expenditures | -0.83M | -1.41M | -0.60M | -1.08M | -0.29M | -1.06M | -0.45M | -0.55M | -0.34M | -0.38M | -0.30M | -0.42M | -0.16M | ||
| Sales of Property, Plant and Equipment | -0.01M | ||||||||||||||
| Change in Intangibles | -72.06M | -70.98M | -10.25M | -12.37M | -0.04M | -0.46M | -0.60M | -2.15M | |||||||
| Cash from Investing Activities | -69.44M | -68.76M | -13.34M | -15.94M | -0.30M | -1.05M | -0.42M | -0.27M | |||||||
| Financing Activities | |||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||
| Long-Term Debt Repayments | -0.82M | -2.19M | -1.13M | -2.68M | -1.36M | -2.37M | -1.02M | -2.07M | -1.74M | -2.54M | -4.76M | -9.55M | -10.37M | ||
| Misc. | |||||||||||||||
| Cash from Financing Activities | -0.87M | -1.32M | -1.40M | -1.48M | -1.02M | -1.87M | -1.36M | -2.12M | -4.66M | -6.42M | |||||
| Exchange Rate Effect | -0.00M | -0.01M | -0.21M | -0.55M | -0.71M | -0.44M | -0.28M | -0.54M | |||||||
| Change in Cash | 171.15M | 223.47M | -78.81M | 164.73M | -37.79M | 110.71M | -19.93M | 91.71M | -14.65M | 76.03M | -4.50M | -44.59M | |||
| Free Cash Flow | 0.83M | 1.41M | -63.31M | -60.64M | -37.24M | -65.81M | 0.45M | -19.00M | -12.15M | -34.65M | 0.30M | -6.95M | -61.25M | ||
| Net Cash Flow | -70.31M | -68.76M | -78.57M | -79.07M | -39.30M | -67.92M | -1.45M | -21.41M | -14.11M | -37.15M | -4.66M | -13.79M | -61.41M |
Pull Innate Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=IPHA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "IPHA", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=IPHA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();